Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results database.

IF 1.8 Q3 ONCOLOGY
Journal of Cancer Epidemiology Pub Date : 2014-01-01 Epub Date: 2014-11-05 DOI:10.1155/2014/680126
Christina K Lettieri, Pamela Garcia-Filion, Pooja Hingorani
{"title":"Incidence and outcomes of desmoplastic small round cell tumor: results from the surveillance, epidemiology, and end results database.","authors":"Christina K Lettieri,&nbsp;Pamela Garcia-Filion,&nbsp;Pooja Hingorani","doi":"10.1155/2014/680126","DOIUrl":null,"url":null,"abstract":"<p><p>Desmoplastic small round cell tumor (DSRCT) is a rare but highly fatal malignancy. Due to the rarity of this neoplasm, no large population based studies exist. Procedure. This is a retrospective cohort analysis. Incidence rates were calculated based on sex and ethnicity and compared statistically. Gender-, ethnicity-, and treatment- based survival were calculated using the Kaplan-Meier method. Results. A total of 192 cases of DSRCT were identified. Peak incidence age was between 20 and 24 years. Age-adjusted incidence rate for blacks was 0.5 cases/million and for whites was 0.2 cases/million (P = 0.037). There was no statistically significant difference in survival based on gender or ethnicity. When adjusted for age, there was no statistically significant difference in survival amongst patients who received radiation therapy compared to those who did not (HRadj = 0.73; 95% CI 0.49, 1.11). There was a statistically significant survival advantage for patients who received radiation after surgery compared to those who did not (HR 0.49; 95% CI 0.30, 0.79). Conclusion. DSRCT is more common in males and in people of African-American descent. Although overall survival remains poor, radiation therapy following surgery seems to improve outcome in these patients. </p>","PeriodicalId":15366,"journal":{"name":"Journal of Cancer Epidemiology","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/680126","citationCount":"75","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/680126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/11/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 75

Abstract

Desmoplastic small round cell tumor (DSRCT) is a rare but highly fatal malignancy. Due to the rarity of this neoplasm, no large population based studies exist. Procedure. This is a retrospective cohort analysis. Incidence rates were calculated based on sex and ethnicity and compared statistically. Gender-, ethnicity-, and treatment- based survival were calculated using the Kaplan-Meier method. Results. A total of 192 cases of DSRCT were identified. Peak incidence age was between 20 and 24 years. Age-adjusted incidence rate for blacks was 0.5 cases/million and for whites was 0.2 cases/million (P = 0.037). There was no statistically significant difference in survival based on gender or ethnicity. When adjusted for age, there was no statistically significant difference in survival amongst patients who received radiation therapy compared to those who did not (HRadj = 0.73; 95% CI 0.49, 1.11). There was a statistically significant survival advantage for patients who received radiation after surgery compared to those who did not (HR 0.49; 95% CI 0.30, 0.79). Conclusion. DSRCT is more common in males and in people of African-American descent. Although overall survival remains poor, radiation therapy following surgery seems to improve outcome in these patients.

Abstract Image

Abstract Image

结缔组织增生小圆细胞瘤的发病率和预后:来自监测、流行病学和最终结果数据库的结果。
结缔组织增生小圆细胞瘤(DSRCT)是一种罕见但高度致命的恶性肿瘤。由于这种肿瘤的罕见性,没有大规模的基于人群的研究存在。过程。这是一项回顾性队列分析。发病率根据性别和种族计算,并进行统计比较。使用Kaplan-Meier方法计算基于性别、种族和治疗的生存率。结果。共发现192例DSRCT。发病高峰年龄为20 ~ 24岁。黑人年龄调整后的发病率为0.5例/百万,白人为0.2例/百万(P = 0.037)。基于性别或种族的生存率没有统计学上的显著差异。经年龄调整后,接受放射治疗的患者与未接受放射治疗的患者的生存率无统计学意义差异(HRadj = 0.73;95% ci 0.49, 1.11)。术后接受放射治疗的患者与未接受放射治疗的患者相比有统计学上显著的生存优势(HR 0.49;95% ci 0.30, 0.79)。结论。DSRCT在男性和非裔美国人后裔中更为常见。尽管总体生存率仍然很低,但手术后放射治疗似乎改善了这些患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
0.00%
发文量
10
审稿时长
20 weeks
期刊介绍: Journal of Cancer Epidemiology is a peer-reviewed, open access journal that publishes original research articles, review articles, case reports, and clinical studies in all areas of cancer epidemiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信